Mylan News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.06.18	InventHelp Inventor Develops Tracking System for Packages (DPH-305) (PR Newswire)
25.05.18	InventHelp Inventor Develops Line of Easy-To-Clean Area Rugs (SDB-1173) (PR Newswire)
07.02.17	How These Generic Drugs Stocks are Faring? -- Mylan, Allergan, Horizon Pharma, and Catalent (PR Newswire)
03.02.17	Mylan to Host Investor Day on March 1, 2017 in New York City (PR Newswire)
31.01.17	EpiPen Maker Faces Anti-Trust Probe (RTTNews)
31.01.17	AEZS Inches Closer To D-Day, EYEG Catches Investors' Eyes, MCRB On Watch (RTTNews)
31.01.17	Mylan Wins U.S. Court Ruling On Copaxone 40 Mg/mL Patents (RTTNews)
19.01.17	Kaleo EpiPen Rival Will Cost $360 If Not Free (RTTNews)
13.01.17	CVS Offering Cheap Generic Alternative To EpiPen (RTTNews)
12.01.17	FDA Says No To TSRO, Ablynx On Track, MYL Leads In Herceptin Biosim Race In U.S. (RTTNews)
11.01.17	FDA Accepts BLA For Mylan And Biocon' Proposed Biosimilar Trastuzumab (RTTNews)
11.01.17	U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Trastuzumab (PR Newswire)
09.01.17	Mylan To Buy Cold-EEZE Brand From ProPhase Labs (RTTNews)
09.01.17	Mylan Acquires Cold-EEZE® Brand to Further Expand OTC Business (PR Newswire)
04.01.17	Technical Reports on Generic Drugs Stocks -- Mylan, Allergan, Horizon Pharma, and Catalent (PR Newswire)
30.12.16	Mylan Posting Strong Gain After Launching Generic Concerta, Cerebyx (RTTNews)
29.12.16	Mylan Launches Generic Concerta® Tablets (PR Newswire)
29.12.16	Mylan Launches Generic Cerebyx® Injection (PR Newswire)
28.12.16	Mylan Launches Generic Zovia® Tablets (PR Newswire)
27.12.16	Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon's Proposed Biosimilar Trastuzumab Phase 3 Data (PR Newswire)
16.12.16	Mylan Launches Authorized Generic For EpiPen Auto-Injector - Quick Facts (RTTNews)
16.12.16	Mylan Launches the First Generic for EpiPen® (epinephrine injection, USP) Auto-Injector as an Authorized Generic (PR Newswire)
09.12.16	Allergan Says Dissapointed In PTAB's Decision On RESTASIS Patents (RTTNews)
05.12.16	Rosen Law Firm Reminds Mylan N.V. Investors of Important Dec. 12 Deadline in Class Action Filed by Firm - MYL (PR Newswire)
01.12.16	Mylan's Commitment to Stemming the Tide of HIV/AIDS as Strong as Ever (PR Newswire)
01.12.16	Technical Reports on Generic Drugs Stocks -- Mylan, Horizon Pharma, Allergan, and Catalent (PR Newswire)
01.12.16	It's All Green For BLUE, HTBX Plunges On Failed Study, Watch Out For BPMC (RTTNews)
28.11.16	Mylan Signs Sub-license Agreement with the Medicines Patent Pool to Increase Access to Hepatitis C Treatment in Developing Countries (PR Newswire)
25.11.16	SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Mylan N.V. To Contact The Firm Before Lead Plaintiff Deadline (PR Newswire)
09.11.16	Mylan Swings To Q3 Loss (RTTNews)
09.11.16	Mylan N.V. Reveals 1% Fall In Q3 Earnings (RTTNews)
09.11.16	ARWR's Hepatitis B Drug On Clinical Hold, GMED Disappoints, A First For MYL (RTTNews)
08.11.16	Mylan Announces Submission Of BLA For Proposed Biosimilar Trastuzumab (RTTNews)
26.10.16	EpiPen Rival Set For Return (RTTNews)
20.10.16	Mylan: Revefenacin Meets Primary Efficacy Endpoint, Shown To Be Well-Tolerated (RTTNews)
10.10.16	Mylan Pulls Back Off Early Highs But Remains Firmly Positive (RTTNews)
04.10.16	Congress Seeks More Information On Mylan's EpiPen Profits (RTTNews)
15.09.16	Congress To Investigate EpiPen Pricing; Mylan CEO To Testify (RTTNews)
06.09.16	NY Opens Probe Into EpiPen Sales To Schools (RTTNews)
30.08.16	KBIO In Detox Mode, CTIC Abuzz, MYL Does Damage Control, D-Day For RIGL (RTTNews)
29.08.16	Mylan To Launch First Generic To EpiPen At Above 50% Discount To Brand Product (RTTNews)
26.08.16	VNDA Soars, CEMI Secures Zika Contract, EMA To Review MYL's Proposed Biosimilar (RTTNews)
25.08.16	Demonized EpiPen Maker Mylan To Offer Discounts (RTTNews)
25.08.16	Mylan Says Taking Action To Further Enhance Access To EpiPen Auto-Injector (RTTNews)
25.08.16	Mylan: EMA To Review MAA For Proposed Biosimilar Trastuzumab - Quick Facts (RTTNews)
09.08.16	Mylan N.V. Reports 25% Advance In Q2 Earnings (RTTNews)
05.08.16	Mylan Closes Acquisition Of Meda (RTTNews)
28.07.16	Mylan Gets U.S. FTC Clearance For Proposed Meda Acquisition (RTTNews)
11.07.16	Mylan Launches Generic Version Of Merck's Temodar - Quick Facts (RTTNews)
06.07.16	Mylan Unveils Generic Fenoglide Tablets (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

05.02.20		US-Pharmakonzern Biogen wehrt Patentklage von Mylan ab
05.09.18		Mylan übernimmt Rechte an Tobi-Inhalator von Novartis
09.08.17		Preisdruck bereitet Generikahersteller Mylan Probleme
13.03.17		Roche und Genentech einigen sich mit Mylan über Herceptin-Biosimilar
25.08.16		Mylan beugt sich dem politischen Druck
13.11.15		Mylan scheitert mit Einverleibung von Perrigo
14.09.15		Perrigo-Aktionäre können entscheiden
28.05.15		Mylan bringt Novartis und Pfizer ins Spiel

05.02.20

US-Pharmakonzern Biogen wehrt Patentklage von Mylan ab

05.09.18

Mylan übernimmt Rechte an Tobi-Inhalator von Novartis

09.08.17

Preisdruck bereitet Generikahersteller Mylan Probleme

13.03.17

Roche und Genentech einigen sich mit Mylan über Herceptin-Biosimilar

25.08.16

Mylan beugt sich dem politischen Druck

13.11.15

Mylan scheitert mit Einverleibung von Perrigo